Dynavax Technologies Corp (NASDAQ:DVAX)

23.31
Delayed Data
As of Apr 24
 -0.38 / -1.60%
Today’s Change
12.50
Today|||52-Week Range
26.89
+38.26%
Year-to-Date

Today’s Trading

Previous close23.69
Today’s open23.61
Day’s range23.29 - 23.95
Volume263,604
Average volume (3 months)436,721
Market cap$674.3M
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)-3.63%
Earnings growth (next 5 years)--
Revenue growth (last year)-1.95%
P/E ratioNM
Price/Sales40.18
Price/Book6.10

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...-0.12-1.86%
AMPHAmphastar Pharmaceut...-0.04-0.26%
ENTAEnanta Pharmaceutica...+0.56+1.53%
VTLVital Therapies Inc+0.19+0.65%
Data as of 3:59pm ET, 04/24/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.95
Annual revenue (last year)$11.0M
Annual profit (last year)-$90.7M
Net profit margin-822.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers